
April 6, 2022 – Second Booster Study, New Omicron Strain
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Arthur Reingold, professor of epidemiology and Head of the Division of Epidemiology and Biostatistics at UC Berkeley’s School of Public Health.
Topics today include:
-
Israeli study finds second booster offered short-term protection against Omicron.
-
Cases rise in San Diego and San Francisco.
- Why haven’t cases risen throughout the United States?
- CA lifts its proof of vaccination for indoor mega events.
- United Kingdom detects omicron XE, a new variant.
- Risk management for immunocompromised people.
- COVID-19 concerns dropping in the United States.
- Recent clinical studies could lead to vaccines that are easier to store.
- NYT: FDA suspends Glaxo’s antibody drug.
- President Biden’s global COVID-19 summit postponed.
This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.
Todavía no hay opiniones